Back to search
FDAFDA · Food and drugs·Recall number D-0268-2024

Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA, NDC 63304-175-13.

Published January 31, 2024 · Recall initiated: January 18, 2024

Summary

FDA records drug Class II recall D-0268-2024, published January 31, 2024 and initiated January 18, 2024. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Completed; Reported quantity: 10,690 bottles; Lot: Lot #s: DNE0875A Exp. 01/31/2025; DNE0876A, DNE0877A, DNE1080A, DNE1081A Exp. 02/28/2025; DNE1147A, DNE1148A Exp. 03/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

What to do

Voluntary: Firm initiated · Letter

Get an email if MESALAMINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MESALAMINE
Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
Nationwide in the USA
Lot
Lot #s: DNE0875A Exp. 01/31/2025; DNE0876A, DNE0877A, DNE1080A, DNE1081A Exp. 02/28/2025; DNE1147A, DNE1148A Exp. 03/31/2025.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA, NDC 63304-175-13. recalled?

Yes. FDA published recall D-0268-2024 on January 31, 2024. Reported hazard: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MESALAMINE.